Solventum (SOLV) Cash & Equivalents (2023 - 2026)

Solventum has reported Cash & Equivalents for 4 years, with the latest figure at $561.0 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 5.06% year-over-year to $561.0 million; the trailing twelve-month figure through Mar 2026 stood at $561.0 million (up 5.06% YoY), and the FY2025 full-year result was $878.0 million, up 15.22% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $561.0 million, down from $878.0 million in the prior quarter.
• The five-year high for Cash & Equivalents was $1.6 billion in Q3 2025, with the low at $194.0 million in Q4 2023.
• Historically, Cash & Equivalents has averaged $772.8 million across 4 years, with a median of $767.0 million in 2024.
• Annual changes were most pronounced in 2024 — Cash & Equivalents surged 292.78% — and 2025, when it tumbled 46.39%.
• Solventum's Cash & Equivalents stood at $194.0 million in 2023, then surged by 292.78% to $762.0 million in 2024, then gained by 15.22% to $878.0 million in 2025, then plunged by 36.1% to $561.0 million in 2026.
• The last three Cash & Equivalents figures came in at $561.0 million (Q1 2026), $878.0 million (Q4 2025), and $1.6 billion (Q3 2025), per Business Quant data.